Article

Performance of free prostate-specific antigen ratio in differentiating between prostatic cancer and benign prostatic lesions at a referral hospital in South Africa

Published in: South African Family Practice
Volume 60 , issue 4 , 2018 , pages: 103–106

DOI: 10.1080/20786190.2018.1432139

Author(s): Boitumelo Phiri-Ramongane Department of Chemical Pathology, South Africa , Ayeaye Khine Department of Chemical Pathology, South Africa

Keywords: diagnostic accuracy , non-communicable diseases , prostatic neoplasm , screening

Download full text Get new issue alerts

Abstract

Background: Prostate cancer is a leading cause of morbidity and mortality in our male population, thus screening initiatives will help to improve outcomes. The current screening marker, total prostate-specific antigen (PSA), is not prostate cancer specific. The development of percentage free PSA (%FPSA) has largely improved the detection of prostate cancer.

« An exploration of the reasons women give for choosing legal termination of pregnancy at Soshanguve Community Health Centre, Pretoria, South Africa

Comment on ‘Cell phone use and ill health: is there a definite relationship?’ »